Applied DNA Sciences (NASDAQ:APDN) Now Covered by StockNews.com

Stock analysts at StockNews.com began coverage on shares of Applied DNA Sciences (NASDAQ:APDN) in a report released on Wednesday. The brokerage set a “sell” rating on the technology company’s stock.

Separately, HC Wainwright dropped their price objective on Applied DNA Sciences from $7.00 to $1.50 and set a “buy” rating on the stock in a research note on Monday, June 10th.

Applied DNA Sciences Price Performance

Shares of APDN opened at $0.38 on Wednesday. The firm has a market capitalization of $369,375.00, a PE ratio of -0.02 and a beta of 0.08. The firm has a 50-day moving average price of $0.53 and a 200 day moving average price of $5.88. Applied DNA Sciences has a 52-week low of $0.33 and a 52-week high of $37.00.

Applied DNA Sciences (NASDAQ:APDN) last posted its quarterly earnings data on Friday, May 10th. The technology company reported ($5.31) earnings per share (EPS) for the quarter, missing the consensus estimate of ($4.60) by ($0.71). Applied DNA Sciences had a negative net margin of 222.33% and a negative return on equity of 306.32%. The company had revenue of $0.93 million during the quarter, compared to the consensus estimate of $0.90 million. On average, equities analysts expect that Applied DNA Sciences will post -2.95 EPS for the current year.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Applied DNA Sciences stock. AMH Equity Ltd lifted its stake in shares of Applied DNA Sciences, Inc. (NASDAQ:APDN) by 46.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 540,385 shares of the technology company’s stock after acquiring an additional 170,385 shares during the quarter. AMH Equity Ltd owned 63.57% of Applied DNA Sciences worth $222,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 22.22% of the company’s stock.

Applied DNA Sciences Company Profile

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.